Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing-Reference-Cited by-同舟云学术

Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing

Published:2020-06 Issue: Volume:20 Page:480-490
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Yang Yu-Chan,Chen Yu-Hsiang,Kao Jia-Horng,Ching Chi,Liu I-Jung,Wang Chih-Chiang,Tsai Cheng-Hsueh,Wu Fang-Yi,Liu Chun-Jen,Chen Pei-Jer,Chen Ding-Shinn,Yang Hung-Chih

Funder

National Taiwan University Hospital

MOST

Cardinal Tien Junior College of Healthcare and Management

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference46 articles.

1. Revisiting the natural history of chronic HBV infection;Yang;Curr. Hepatol. Rep.,2016

2. Discontinuation of oral antivirals in chronic hepatitis B: A systematic review;Papatheodoridis;Hepatology,2016

3. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B;Nassal;Gut,2015

4. Hepatitis B cure: from discovery to regulatory approval;Lok;Hepatology,2017

5. A global scientific strategy to cure hepatitis B;Revill;Lancet Gastroenterol. Hepatol.,2019

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tackling hepatitis B Virus with CRISPR/Cas9: advances, challenges, and delivery strategies;Virus Genes;2024-08-28

2. Testing multiplexed anti-ASFV CRISPR-Cas9 in reducing African swine fever virus;Microbiology Spectrum;2024-07-02

3. Hepatitis B virus DNA integration: Implications for diagnostics, therapy, and outcome;Journal of Hepatology;2024-07

4. CRISPR-Cas13b-mediated suppression of HBV replication and protein expression;Journal of Hepatology;2024-05

5. Establishment of a hydrodynamic delivery system in ducks;Transgenic Research;2024-03-09